The papain-like protease of coronaviruses cleaves ULK1 to disrupt host autophagy
Y. Mohamud, Y. Chao Xue, H. Liu, C. Seng Ng, A. Bahreyni, E. Jan, H. Luo
Abstract
The ongoing pandemic of COVID-19 alongside the outbreaks of SARS in 2003 and MERS in 2012 underscore the significance to understand betacoronaviruses as a global health challenge. SARS-CoV-2, the etiological agent for COVID-19, has infected more than 29 million individuals worldwide with nearly ~1 million fatalities. Understanding how SARS-CoV-2 initiates viral pathogenesis is of the utmost importance for development of antiviral drugs. Autophagy modulators have emerged as potential therapeutic candidates against SARS-CoV-2 but recent clinical setbacks underline the urgent need for better understanding the mechanism of viral subversion of autophagy. Using murine hepatitis virus-A59 (MHV-A59) as a model betacoronavirus, time-course infections revealed a significant loss in the protein level of ULK1, a canonical autophagy regulating serine-threonine kinase, and the concomitant appearance of a possible cleavage fragment. To investigate whether virus-encoded proteases target this protein, we conducted in vitro and cellular cleavage assays and identified ULK1 as a novel bona fide substrate of SARS-CoV-2 papain-like protease (PLpro). Mutagenesis studies discovered that ULK1 is cleaved at a conserved PLpro recognition sequence (LGGG) after G499, separating its N-terminal kinase domain from the C-terminal substrate recognition region. Consistent with this, over-expression of SARS-CoV-2 PLpro is sufficient to impair starvation-induced canonical autophagy and disrupt formation of ULK1-ATG13 complex. Finally, we demonstrated a dual role for ULK1 in MHV-A59 replication, serving a pro-viral functions during early replication that is inactivated at late stages of infection. In conclusion, our study identified a new mechanism by which PLpro of betacoronaviruses induces viral pathogenesis by targeting cellular autophagic pathway (Word count=250) IMPORTANCEThe recent COVID-19 global pandemic alongside the 2003 SARS and 2012 MERS outbreaks underscore an urgent need to better understand betacoronaviruses as pathogens that pose global challenge to human health. Studying the underlying biology of how betacoronaviruses subvert innate cellular defense pathways such as autophagy will help to guide future efforts to develop anti-viral therapy. (Word count= 55)
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- ORF3a mediated-incomplete autophagy facilitates SARS-CoV-2 replication
- SARS-CoV-2 envelope protein induces LC3 lipidation via the V-ATPase-ATG16L1 axis
Carmen Figueras-Novoa, Lewis Timimi, … Rupert C. L. Beale·bioRxiv·Jun 12, 2025
- Mechanism and inhibition of SARS-CoV-2 PLpro
T. Klemm, G. Ebert, … D. Komander·bioRxiv·Jun 18, 2020
- Characterisation of protease activity during SARS-CoV-2 infection identifies novel viral cleavage sites and cellular targets with therapeutic potential
B. Meyer, J. Chiaravalli, … E. Emmott·bioRxiv·Sep 16, 2020
- Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors
J. Osipiuk, Saara‐Anne Azizi, … A. Joachimiak·Nature CommunicationsPeer-reviewed·Feb 2, 2021
- SARS-CoV-2 PLpro whole human proteome cleavage prediction and enrichment/depletion analysis
Lucas Prescott·bioRxiv·Oct 4, 2021